CCKBR and medullary thyroid gland carcinoma: Due to the high overexpression of the cholecystokinin receptor subtype 2 (CCK-2R) on MTC cells (incidence of > 90%) [1–3], it has been proposed that CCK-2R targeting peptides may serve as vectors for diagnostic imaging and TRNT of MTC.